Craig Winter
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Craig Winter has a total of 23 co-authors. Here are the top co-authors by number of shared publications:
- Alan Coulthard
Department of Medical Imaging Royal Brisbane and Women's Hospital Brisbane Queensland Australia
1 shared publication - Ashley R. Murphy
School of Chemical Engineering, The University of Queensland, St Lucia, Australia
1 shared publication - Chloe M. de Nys
School of Chemical Engineering, The University of Queensland, St Lucia, Australia
1 shared publication - Danilo Carluccio
Department of Oral and Maxillofacial Surgery, Royal Brisbane and Women's Hospital, Brisbane, Queensland, Australia; Herston Biofabrication Institute, Metro North Health, Brisbane, Queensland, Australia; School of Dentistry, The University of Queensland, Brisbane, Queensland, Australia
1 shared publication Ee Shern Liang
Department of Medical Imaging, Royal Brisbane and Womens Hospital (RBWH), Herston, Australia
1 shared publication- Emma Ballard
QIMR Berghofer Medical Research Institute
1 shared publication
Latest Publications
- Open Access
- 6 September 2025
- Published by Springer Nature in Acta Neurochirurgica
- Vol. 167 (1) , 1-11
Haemodynamic characteristics of thin-walled regions in intracranial aneurysms: intraoperative imaging and CFD analysis
Background: Identifying haemodynamic factors associated with thin-walled regions (TWRs) of intracranial aneurysms is critical for improving pre-surgical rupture risk assessment. Intraoperatively, these regions are visually distinguished by a red, translucent appearance and are considered highly rupture prone. However, current imaging modalities lack the resolution to detect such vulnerable areas preoperatively. This study aimed to determine whether thin-walled regions exhibit distinct local haemodynamic profiles compared to adjacent normal-appearing wall regions. Methods: Sixteen patient-specific models of unruptured middle cerebral artery aneurysms were reconstructed from digital subtraction angiography images. Intraoperative TWRs were identified using a colour segmentation method based on Delta E metrics. Computational fluid dynamics (CFD) simulations were used to compute six haemodynamic parameters: wall shear stress (WSS), time-averaged WSS (TaWSS), oscillatory shear index (OSI), relative residence time (RRT), WSS divergence (WSSD), and pressure. Haemodynamic data were extracted from spatially localised surface patches within confirmed thin and normal regions. Linear mixed-effects models were applied to compare parameters while accounting for patient-level and intra-patient variability, using normalised values to improve model fit. Results: Thin regions exhibited significantly higher WSS, TaWSS, WSSD, and pressure, and reduced RRT. WSS and TaWSS were approximately 3.3% and 2.8% higher in TWRs, respectively. WSSD was 5.4% higher and RRT was 0.3% lower, suggesting faster, more divergent flow in thin regions. Pressure was modestly but significantly elevated at + 1.3%. No significant difference was observed in OSI between regions. Conclusions: Thin-walled regions in intracranial aneurysms demonstrate a distinctive haemodynamic profile characterised by stronger, sustained shear forces, greater shear divergence, and reduced residence time, suggesting a dynamic mechanical environment that promotes focal wall thinning. Our findings suggest that persistent shear-driven stress, rather than oscillatory flow, is a key haemodynamic feature of thin-walled regions and may contribute to localised aneurysm wall vulnerability.
- 6 September 2025
- Published by Springer Nature in Acta Neurochirurgica
- Vol. 167 (1) , 1-11
Open AccessHaemodynamic characteristics of thin-walled regions in intracranial aneurysms: intraoperative imaging and CFD analysis
Background: Identifying haemodynamic factors associated with thin-walled regions (TWRs) of intracranial aneurysms is critical for improving pre-surgical rupture risk assessment. Intraoperatively, these regions are visually distinguished by a red, translucent appearance and are considered highly rupture prone. However, current imaging modalities lack the resolution to detect such vulnerable areas preoperatively. This study aimed to determine whether thin-walled regions exhibit distinct local haemodynamic profiles compared to adjacent normal-appearing wall regions. Methods: Sixteen patient-specific models of unruptured middle cerebral artery aneurysms were reconstructed from digital subtraction angiography images. Intraoperative TWRs were identified using a colour segmentation method based on Delta E metrics. Computational fluid dynamics (CFD) simulations were used to compute six haemodynamic parameters: wall shear stress (WSS), time-averaged WSS (TaWSS), oscillatory shear index (OSI), relative residence time (RRT), WSS divergence (WSSD), and pressure. Haemodynamic data were extracted from spatially localised surface patches within confirmed thin and normal regions. Linear mixed-effects models were applied to compare parameters while accounting for patient-level and intra-patient variability, using normalised values to improve model fit. Results: Thin regions exhibited significantly higher WSS, TaWSS, WSSD, and pressure, and reduced RRT. WSS and TaWSS were approximately 3.3% and 2.8% higher in TWRs, respectively. WSSD was 5.4% higher and RRT was 0.3% lower, suggesting faster, more divergent flow in thin regions. Pressure was modestly but significantly elevated at + 1.3%. No significant difference was observed in OSI between regions. Conclusions: Thin-walled regions in intracranial aneurysms demonstrate a distinctive haemodynamic profile characterised by stronger, sustained shear forces, greater shear divergence, and reduced residence time, suggesting a dynamic mechanical environment that promotes focal wall thinning. Our findings suggest that persistent shear-driven stress, rather than oscillatory flow, is a key haemodynamic feature of thin-walled regions and may contribute to localised aneurysm wall vulnerability.
- Open Access
Additive manufacturing of patient-specific intracranial aneurysm cell culture models
Intracranial aneurysms (IAs) are present in 2-6% of the global population. While rare, rupture results in mortality rates of 30-50% and lifelong disabilities in survivors. While treatment of unruptured IAs carries its own risk of mortality, there are no rigid guidelines indicating which IA presentation is at greater risk of rupture. We develop and evaluate the suitability of various additive manufacturing processes to fabricate patient-specific IA culture models for understanding IA pathophysiology and thereby support future development of a rupture risk prediction tool. Material compatibility of several 3D printed resins, polydimethylsiloxane (PDMS) and collagen gel with immortalised human brain endothelial cells (HBECs) were investigated. Patient angiograms were segmented to produce in vitro models via two fabrication approaches: stereolithography (SLA) 3D printing versus chocolate injection moulding of a sacrificial core embedded in PDMS. These 3D arterial models were then cellularised with HBECs, and geometric accuracy and distension properties evaluated. PDMS, collagen gel and the elastic50A resin materials supported cellularisation on material surfaces with high cell viability and proliferation. Both the 3D printed resin and injection moulding techniques successfully fabricated patient-specific basilar artery IA models with a Dice-Sørensen coefficient of over 90%. However, only PDMS models offered complete cell coverage in 3D geometries. This exceeds current benchmarks on IA fabrication accuracy. Through controlling IA model wall thickness, we demonstrate the ability to create localised distension under pressure in the context of thin– and thick-walled aneurysms. In vitro IA models present a promising platform for investigating IA pathophysiology and rupture risk. The novel chocolate sacrificial core technique offers a biocompatible, support-free fabrication method suitable for 3D cultures. Given the independent effects of fluid dynamics and mechanical strain on cell behaviour, it is essential to characterise distension under pressure and ensure accurate fabrication for reliable analysis into cell behaviour.
Open AccessAdditive manufacturing of patient-specific intracranial aneurysm cell culture models
Intracranial aneurysms (IAs) are present in 2-6% of the global population. While rare, rupture results in mortality rates of 30-50% and lifelong disabilities in survivors. While treatment of unruptured IAs carries its own risk of mortality, there are no rigid guidelines indicating which IA presentation is at greater risk of rupture. We develop and evaluate the suitability of various additive manufacturing processes to fabricate patient-specific IA culture models for understanding IA pathophysiology and thereby support future development of a rupture risk prediction tool. Material compatibility of several 3D printed resins, polydimethylsiloxane (PDMS) and collagen gel with immortalised human brain endothelial cells (HBECs) were investigated. Patient angiograms were segmented to produce in vitro models via two fabrication approaches: stereolithography (SLA) 3D printing versus chocolate injection moulding of a sacrificial core embedded in PDMS. These 3D arterial models were then cellularised with HBECs, and geometric accuracy and distension properties evaluated. PDMS, collagen gel and the elastic50A resin materials supported cellularisation on material surfaces with high cell viability and proliferation. Both the 3D printed resin and injection moulding techniques successfully fabricated patient-specific basilar artery IA models with a Dice-Sørensen coefficient of over 90%. However, only PDMS models offered complete cell coverage in 3D geometries. This exceeds current benchmarks on IA fabrication accuracy. Through controlling IA model wall thickness, we demonstrate the ability to create localised distension under pressure in the context of thin– and thick-walled aneurysms. In vitro IA models present a promising platform for investigating IA pathophysiology and rupture risk. The novel chocolate sacrificial core technique offers a biocompatible, support-free fabrication method suitable for 3D cultures. Given the independent effects of fluid dynamics and mechanical strain on cell behaviour, it is essential to characterise distension under pressure and ensure accurate fabrication for reliable analysis into cell behaviour.
- Open Access
- 21 October 2021
- Published by Frontiers Media SA in Frontiers in Physiology
- Vol. 12
Acute Mountain Sickness Following Incremental Trekking to High Altitude: Correlation With Plasma Vascular Endothelial Growth Factor Levels and the Possible Effects of Dexamethasone and Acclimatization Following Re-exposure
Purpose: The recognition and treatment of high-altitude illness (HAI) is increasingly important in global emergency medicine. High altitude related hypobaric hypoxia can lead to acute mountain sickness (AMS), which may relate to increased expression of vascular endothelial growth factor (VEGF), and subsequent blood-brain barrier (BBB) compromise. This study aimed to establish the relationship between AMS and changes in plasma VEGF levels during a high-altitude ascent. VEGF level changes with dexamethasone, a commonly used AMS medication, may provide additional insight into AMS.Methods: Twelve healthy volunteers ascended Mt Fuji (3,700 m) and blood samples were obtained at distinct altitudes for VEGF analysis. Oxygen saturation (SPO2) measurements were also documented at the same time-point. Six out of the 12 study participants were prescribed dexamethasone for a second ascent performed 48 h later, and blood was again collected to establish VEGF levels.Results: Four key VEGF observations could be made based on the data collected: (i) the baseline VEGF levels between the two ascents trended upwards; (ii) those deemed to have AMS in the first ascent had increased VEGF levels (23.8–30.3 pg/ml), which decreased otherwise (23.8–30.3 pg/ml); (iii) first ascent AMS participants had higher VEGF level variability for the second ascent, and similar to those not treated with dexamethasone; and (iv) for the second ascent dexamethasone participants had similar VEGF levels to non-AMS first ascent participants, and the variability was lower than for first ascent AMS and non-dexamethasone participants. SPO2 changes were unremarkable, other than reducing by around 5% irrespective of whether measurement was taken for the first or second ascent.Conclusion: First ascent findings suggest a hallmark of AMS could be elevated VEGF levels. The lack of an exercise-induced VEGF level change strengthened the notion that elevated plasma VEGF was brain-derived, and related to AMS.
- 21 October 2021
- Published by Frontiers Media SA in Frontiers in Physiology
- Vol. 12
Open AccessAcute Mountain Sickness Following Incremental Trekking to High Altitude: Correlation With Plasma Vascular Endothelial Growth Factor Levels and the Possible Effects of Dexamethasone and Acclimatization Following Re-exposure
Purpose: The recognition and treatment of high-altitude illness (HAI) is increasingly important in global emergency medicine. High altitude related hypobaric hypoxia can lead to acute mountain sickness (AMS), which may relate to increased expression of vascular endothelial growth factor (VEGF), and subsequent blood-brain barrier (BBB) compromise. This study aimed to establish the relationship between AMS and changes in plasma VEGF levels during a high-altitude ascent. VEGF level changes with dexamethasone, a commonly used AMS medication, may provide additional insight into AMS.Methods: Twelve healthy volunteers ascended Mt Fuji (3,700 m) and blood samples were obtained at distinct altitudes for VEGF analysis. Oxygen saturation (SPO2) measurements were also documented at the same time-point. Six out of the 12 study participants were prescribed dexamethasone for a second ascent performed 48 h later, and blood was again collected to establish VEGF levels.Results: Four key VEGF observations could be made based on the data collected: (i) the baseline VEGF levels between the two ascents trended upwards; (ii) those deemed to have AMS in the first ascent had increased VEGF levels (23.8–30.3 pg/ml), which decreased otherwise (23.8–30.3 pg/ml); (iii) first ascent AMS participants had higher VEGF level variability for the second ascent, and similar to those not treated with dexamethasone; and (iv) for the second ascent dexamethasone participants had similar VEGF levels to non-AMS first ascent participants, and the variability was lower than for first ascent AMS and non-dexamethasone participants. SPO2 changes were unremarkable, other than reducing by around 5% irrespective of whether measurement was taken for the first or second ascent.Conclusion: First ascent findings suggest a hallmark of AMS could be elevated VEGF levels. The lack of an exercise-induced VEGF level change strengthened the notion that elevated plasma VEGF was brain-derived, and related to AMS.